Meta-analysis of 6 observational studies (4,831,654 participants): semaglutide vs non-GLP-1 RA therapies was not significantly associated with NAION (OR 2.44, 0.59-10.15; aHR 1.63, 0.88-2.39), with low to very low certainty and fragile estimates.
Meta-analysisn = 4,831,654
Abdelaal et al. Semaglutide and the Risk of Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Certainty of Evidence Meta-Analysis